Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 2—February 2021
Research

Use of Commercial Claims Data for Evaluating Trends in Lyme Disease Diagnoses, United States, 2010–2018

Amy M. Schwartz, Kiersten J. Kugeler, Christina A. Nelson, Grace E. Marx, and Alison F. HinckleyComments to Author 
Author affiliation: Centers for Disease Control and Prevention, Fort Collins, Colorado, USA

Main Article

Figure 2

Population composition comparison of MarketScan enrollees (A) and US population (B) by age group and sex, United States, 2010–2018.

Figure 2. Population composition comparison of MarketScan enrollees (A) and US population (B) by age group and sex, United States, 2010–2018.

Main Article

Page created: December 10, 2020
Page updated: January 23, 2021
Page reviewed: January 23, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external